Pacer Advisors Inc. reduced its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 113,881 shares of the technology company’s stock after selling 14,771 shares during the quarter. Pacer Advisors Inc. owned 0.07% of Veeva Systems worth $33,926,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of VEEV. Trust Co. of Toledo NA OH bought a new stake in Veeva Systems during the 2nd quarter worth approximately $29,000. Legacy Investment Solutions LLC acquired a new position in shares of Veeva Systems in the second quarter valued at approximately $32,000. Maseco LLP bought a new stake in shares of Veeva Systems during the second quarter worth $35,000. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Veeva Systems by 58.3% during the second quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock worth $38,000 after acquiring an additional 49 shares during the period. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Veeva Systems during the second quarter worth $41,000. Institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Up 0.5%
NYSE:VEEV opened at $224.36 on Friday. Veeva Systems Inc. has a twelve month low of $201.54 and a twelve month high of $310.50. The firm has a market capitalization of $36.88 billion, a price-to-earnings ratio of 43.65, a price-to-earnings-growth ratio of 1.65 and a beta of 1.05. The stock’s 50 day moving average price is $259.07 and its two-hundred day moving average price is $274.78.
Insider Transactions at Veeva Systems
In other news, insider Thomas D. Schwenger sold 3,350 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the sale, the insider directly owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan Faddis sold 14,595 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total value of $4,378,500.00. Following the transaction, the senior vice president owned 8,588 shares of the company’s stock, valued at $2,576,400. The trade was a 62.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 24,665 shares of company stock worth $7,438,000 in the last ninety days. Insiders own 10.30% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and set a $330.00 target price on shares of Veeva Systems in a report on Monday, November 24th. BTIG Research reaffirmed a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research report on Friday, November 21st. KeyCorp reissued a “sector weight” rating on shares of Veeva Systems in a research report on Friday, December 12th. Weiss Ratings restated a “buy (b-)” rating on shares of Veeva Systems in a research note on Monday. Finally, William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a research note on Friday, October 17th. Eighteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $307.42.
Get Our Latest Stock Report on VEEV
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
